Ruel Marc, Suuronen Erik J, Song Jianming, Kapila Varun, Gunning Derek, Waghray Geeta, Rubens Fraser D, Mesana Thierry G
Division of Cardiac Surgery, University of Ottawa, Ottawa, Ontario, Canada.
J Thorac Cardiovasc Surg. 2005 Sep;130(3):633-9. doi: 10.1016/j.jtcvs.2005.01.013.
Off-pump coronary artery bypass grafting may result in fewer myocardial and vascular complications than on-pump. Although differences in aortic manipulations likely play a role, the systemic responses of endothelial progenitor cells to both types of operations have not been examined. We sought to examine endothelial progenitor cell characteristics after off-pump versus on-pump coronary artery bypass grafting.
Twenty patients undergoing off-pump or on-pump coronary artery bypass grafting were prospectively enrolled and had endothelial progenitor cells isolated and cultured from their peripheral blood before and 24 hours after surgery. Endothelial progenitor cells were identified by fluorescent dual lectin/low-density lipoprotein binding. Their number, phenotype characteristics, proliferation, migratory function, and viability were determined in a blinded fashion.
Patient characteristics and numbers of grafts were equivalent. Endothelial progenitor cells had similar phenotypes between groups before and after surgery. Off-pump and on-pump coronary artery bypass grafting resulted in similar increases in endothelial progenitor cell numbers and showed equivalent proliferation activity. However, endothelial progenitor cell migratory function was higher in off-pump patients (25.3 +/- 5.0 vs 5.0 +/- 1.0 cells per high-powered field for off-pump vs on-pump coronary artery bypass grafting, respectively; P = .04). Postoperative endothelial progenitor cell viability adjusted for preoperative baseline was also higher after off-pump than on-pump coronary artery bypass grafting by 72.4% +/- 14.6% (P = .01). Endothelial progenitor cells of on-pump patients were less viable after surgery than before surgery, whereas the reverse was observed in off-pump patients.
Both on-pump and off-pump coronary artery bypass grafting elicit mobilization of endothelial progenitor cells into the peripheral blood. On-pump coronary artery bypass grafting, however, impairs the migratory function and viability of these vascular repair cells, which are conversely preserved after off-pump surgery. Further work is necessary to determine whether the function and viability of endothelial progenitor cells correlate with vascular outcomes and whether their therapeutic modulation may one day benefit coronary artery bypass grafting patients.
非体外循环冠状动脉搭桥术可能比体外循环导致更少的心肌和血管并发症。尽管主动脉操作的差异可能起作用,但内皮祖细胞对这两种手术的全身反应尚未得到研究。我们试图研究非体外循环与体外循环冠状动脉搭桥术后内皮祖细胞的特征。
前瞻性纳入20例行非体外循环或体外循环冠状动脉搭桥术的患者,在手术前和术后24小时从其外周血中分离并培养内皮祖细胞。通过荧光双凝集素/低密度脂蛋白结合鉴定内皮祖细胞。以盲法测定其数量、表型特征、增殖、迁移功能和活力。
患者特征和移植血管数量相当。手术前后两组内皮祖细胞具有相似的表型。非体外循环和体外循环冠状动脉搭桥术导致内皮祖细胞数量相似增加,并显示出同等的增殖活性。然而,非体外循环患者的内皮祖细胞迁移功能更高(非体外循环与体外循环冠状动脉搭桥术分别为每高倍视野25.3±5.0个细胞与5.0±1.0个细胞;P = 0.04)。校正术前基线后的术后内皮祖细胞活力在非体外循环冠状动脉搭桥术后也比体外循环高72.4%±14.6%(P = 0.01)。体外循环患者的内皮祖细胞术后活力低于术前,而非体外循环患者则相反。
体外循环和非体外循环冠状动脉搭桥术均可促使内皮祖细胞动员至外周血。然而,体外循环冠状动脉搭桥术损害了这些血管修复细胞的迁移功能和活力,而非体外循环手术后这些功能则得以保留。有必要进一步研究以确定内皮祖细胞的功能和活力是否与血管转归相关,以及对其进行治疗性调节是否有朝一日能使冠状动脉搭桥术患者受益。